Depersonalization in the Face of Life-Threatening Danger: A Description

Psychiatry ◽  
1976 ◽  
Vol 39 (1) ◽  
pp. 19-27 ◽  
Author(s):  
Russell Noyes ◽  
Roy Kletti
Keyword(s):  
The Face ◽  
PEDIATRICS ◽  
1975 ◽  
Vol 56 (6) ◽  
pp. 1078-1079
Author(s):  
Abdul J. Khan ◽  
Hugh E. Evans ◽  
Marylu R. Macabuhay ◽  
Yu-En Lee ◽  
Robert Werner

Beta-hemolytic Streptococcus group G, a rare human pathogen, has long been implicated in human disease as causing pharyngitis, puerperal sepsis, empyema, and even septicemia. We are reporting a rare, life-threatening, acute illness, primary peritonitis, due to this organism, whose etiological source probably was a family dog. Case Report R.K., a 2-year-old girl, was admitted with the complaints of anorexia, vomiting of three days' duration, and severe abdominal distension of one day's duration. The symptoms started following a burn injury over the face and lips three days prior to admission. Past history was noncontributory. Physical examination revealed an ill child of average size, fully conscious.


2021 ◽  
pp. 003022282110623
Author(s):  
Ramzi Fatfouta ◽  
Radosław Rogoza

Fear is a fundamental response in the face of a life-threatening pandemic, such as COVID-19. To assess COVID-19-related fear, the Fear of COVID-19 Scale (FCV-19S) has been recently developed and validated in many countries across the globe. The current study aimed to adapt the FCV-19S into German and to examine its psychometric properties. Participants ( N = 866) were asked to complete the FCV-19S, report their perceived risk of contracting the virus, and their willingness to comply with mask wearing. Confirmatory Factor Analysis supported both a two-factor structure (emotional and somatic fear) and a more parsimonious one-factor model. Among demographic variables, only female gender was positively associated with the FCV-19S. Moreover, the measure was associated with increased risk perception and compliance with mask wearing. Results suggest that the FCV-19S has good psychometric properties in German and can be used in future work.


2005 ◽  
Vol 25 (4_suppl) ◽  
pp. 77-82 ◽  
Author(s):  
Akira Saito

Encapsulating peritoneal sclerosis (EPS) is a life-threatening complication of peritoneal dialysis (PD). The overall prevalence of EPS in Japanese PD patients is 2.3%. Among patients on PD for less than 5 years, the rate is 0.9%; among patients on PD for 5 – 10 years, the rate is 3.8%; and among patients on PD for >10 years, it is 11.5%. Thus, the longer the treatment duration, the higher the prevalence of EPS. Encapsulating peritoneal sclerosis does not result solely from the natural progression of peritoneal sclerosis. A “second hit” event, such as bacterial peritonitis, abdominal bleeding, or abdominal surgery may be needed to trigger the onset of EPS in the face of advanced peritoneal sclerosis. To prevent development of EPS, PD treatment is replaced by other treatments when patients reached high-transport status. Peritoneal lavage and prednisolone administration have been reported to be effective in preventing or stopping the progress of EPS. When bowel obstruction has occurred, total enterolysis to remove the fibrous capsule from the bowel is indicated. To maximize overall quality of life, patients with end-stage renal disease (ESRD) should have the choice to make use of all the treatment modalities available: PD, hemodialysis (HD), and transplantation. Furthermore, the development of truly biocompatible PD equipment—including peritoneal catheters, solutions, and systems—are desirable to extend PD treatment for the long term. The cost of individual products could decrease significantly if PD use were to increase to 30% from 10% among ESRD patients worldwide. As practitioners, we have to further improve the technical survival rate and functional duration of PD treatment so that adequate peritoneal function can be maintained for 10 years in at least 40% of PD patients. The goal is to place PD on par with HD using high-flux dialysis membranes and ultrapure dialysis solution.


1991 ◽  
Vol 9 (7) ◽  
pp. 1124-1130 ◽  
Author(s):  
A Moliterni ◽  
G Bonadonna ◽  
P Valagussa ◽  
L Ferrari ◽  
M Zambetti

In the attempt to improve current adjuvant results in patients with one to three positive axillary lymph nodes, in November 1981 we activated a prospective randomized study to assess the effectiveness of intravenous (IV) cyclophosphamide, methotrexate, and fluorouracil (CMF) for 12 courses versus CMF for eight courses followed by Adriamycin (doxorubicin; Farmitalia Carlo Erba, Milan, Italy) for four courses. The 5-year results were evaluated in a total of 486 patients entered into the study up to December 1987. CMF chemotherapy was delivered IV for a total of 12 courses when given alone and for eight courses when followed by four courses of Adriamycin. All drugs were recycled every 3 weeks. Rather than temporarily reducing doses, drug administration was delayed for 1 to 2 weeks in the face of myelosuppression on the planned day of treatment. After a median follow-up of 61 months, no significant differences were evident between the treatment groups in terms of relapse-free (CMF 74% v CMF followed by Adriamycin 72%) and total survival (CMF 89% v CMF followed by Adriamycin 86%). Drug treatments were fairly well tolerated and devoid of life-threatening toxicity. Present results, which were not influenced by menopausal status, indicate that Adriamycin given after CMF failed to improve treatment outcome over CMF alone. However, the role of Adriamycin in an adjuvant setting remains to be further clarified. Considering the good 5-year results achieved in this study at the expense of minimal toxicity, full-dose CMF remains, at present, the adjuvant chemotherapy of choice for patients with one to three positive nodes.


1997 ◽  
Vol 36 (1) ◽  
pp. 23-32 ◽  
Author(s):  
Kemi Adamolekun

Most physicians in developed countries are reported to have a sense of responsibility to inform a patient about the facts of his or her life-threatening condition. This study reports doctors' and nurses' responsibility to their terminally ill patients in an African environment. Since, by local tradition, doctors are not supposed to convey bad news and the patients do not see themselves as dying of illness, the doctors are not enthusiastic about informing the patients that their disease is terminal. Though doctors and nurses are of the opinion that patients or relatives should be informed of patients' diagnoses, the majority of these professionals do not discuss the prognosis with terminally ill patients. The need to discuss the diagnosis and prognosis according to the desire of each patient was examined. This is more relevant to the practice of medicine in the developing countries with the likelihood that more terminally ill patients would use the hospitals in the face of HIV/AIDS epidemic.


1996 ◽  
Vol 2 (2) ◽  
pp. 61-68 ◽  
Author(s):  
R. L. Palmer

The severity of anorexia nervosa can vary from mild to life threatening. It is sometimes transient but often chronic. Such variety of disorder requires variety of response. The clinician must choose the right treatment to offer at the right time. The literature contains plenty of advice but most of this is based upon experience and opinion rather than on systematic research and treatment trials. For the most part, this paper will be no exception. Anorexia nervosa is a disorder which is distinct from other psychiatric syndromes but is of uncertain cause. In the face of this uncertainty, treatment tends to be informed by the favoured formulation of the clinician, usually some sort of ‘multifactorial theory’. Again this paper is no exception. It will concentrate upon the management of anorexia nervosa in late adolescence and adulthood. The treatment of children requires a different approach (Lask & Bryant-Waugh, 1993). The emphasis of the paper will be upon what can go wrong as well as what may be the best interventions to offer. Often the things that go wrong have more to do with the context of treatment and the way in which it is offered rather than with the treatment intervention itself.


2012 ◽  
Vol 3 (3) ◽  
pp. 261-264 ◽  
Author(s):  
GK Vivek ◽  
Ranjith Singh ◽  
GC Veena ◽  
Prappanna Arya

ABSTRACT Necrotizing fasciitis is a progressive, life-threatening, bacterial infection of the skin, the subcutaneous tissue and the underlying fascia, in most cases caused by β-hemolytic group A Streptococcus. Only early diagnosis and aggressive therapy including broad spectrum antibiotics and surgical intervention can avoid systemic toxicity with a high mortality rate. This disease is commonly known to occur in the lower extremities and trunk, and only rarely in the head and neck region, the face being rarest finding. When located in the face necrotizing fasciitis is associated with severe cosmetic and functional complication due to the invasive nature, infection and often due to the necessary surgical treatment. In the following article, we present the successful diagnosis and management of an isolated facial necrotizing fasciitis as a consequence of odontogenic infection. How to cite this article Vivek GK, Singh R, Veena GC, Arya P. Necrotizing Fasciitis of Face in Odontogenic Infection: A Rare Clinical Entity. World J Dent 2012;3(3):261-264.


2018 ◽  
Vol 37 (4) ◽  
pp. S475-S476
Author(s):  
L.A. Allen ◽  
C.E. Knoepke ◽  
E.C. Leister ◽  
J.S. Thompson ◽  
C.K. McIlvennan ◽  
...  

2021 ◽  
pp. 155-178
Author(s):  
Jeremy Rawlins ◽  
Isabel Jones

Adult burn injuries are heterogeneous in their aetiology and in their severity, and in the many ways in which they affect the burns patient. Treatment should be initiated promptly, ensuring that other life-threatening injuries are dealt with, and that expert burn care is delivered to the patient. First aid followed by emergency management of the patient, fluid resuscitation, and specialist wound care ensures the patient is given the very best opportunity for full recovery and survival. The burn wound may be managed non-surgically, but for deeper and more severe injuries, surgical debridement and wound cover with grafts, cell suspensions, dermal matrices, or flaps is required. Areas of special attention include the face, hands, and perineum—all functionally and aesthetically important, and each with specific dressing needs and surgical techniques that optimize good outcomes. Scar management and physiotherapy are crucial components of adult burn care, with many therapies applied concurrently to ensure good functional and aesthetic recovery. For those patients with ongoing scar and contracture difficulties, scar therapies and reconstructive burns surgery offer the chance of better function and appearance even many years after the original burn. The journey to recovery would not be complete, however, without important psychosocial input for the burns patient, as the psychological scars are often just as painful as the physical ones.


Sign in / Sign up

Export Citation Format

Share Document